Companies

Aquestive Therapeutics, Inc. (AQST) SEC filings

CIK 0001398733 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)44.5 M50.6 M47.7 M
Net income (USD)-54.4 M-70.5 M
Diluted EPS (USD/shares)-0.78-0.13-1.12

Latest filings

FiledFormDescriptionPeriod
2026-10-198-K8-K items 5.03,9.012026-10-15
2026-10-164PRIMARY DOCUMENT2026-10-15
2026-10-163PRIMARY DOCUMENT2026-10-15
2026-10-158-K8-K items 7.01,9.012026-10-15
2026-10-148-K8-K items 1.01,9.012026-10-13
2026-10-07SCHEDULE 13GSCHEDULE 13G
2026-10-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-298-K8-K items 5.02,9.012026-09-29
2026-09-258-K8-K items 7.01,9.012026-09-23
2026-09-178-K8-K items 7.01,8.01,9.012026-09-14
2026-09-164PRIMARY DOCUMENT2026-09-15
2026-09-15144144
2026-09-114PRIMARY DOCUMENT2026-09-09
2026-09-104PRIMARY DOCUMENT2026-09-09
2026-09-094PRIMARY DOCUMENT2026-09-08
2026-09-09144144
2026-09-084PRIMARY DOCUMENT2026-09-03
2026-08-184PRIMARY DOCUMENT2026-08-17
2026-08-174PRIMARY DOCUMENT2026-08-14
2026-08-17144144
2026-08-1110-Q10-Q2026-06-30
2026-08-118-K8-K items 2.02,7.01,9.012026-08-11
2026-08-108-K8-K items 7.01,8.01,9.012026-08-10
2026-07-27SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-174PRIMARY DOCUMENT2026-07-15

Forms on file (last 1,000): 4 283, 8-K 182, 3 29, 10-Q 25, 144 18, CORRESP 15, 424B5 13, DEFA14A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=AQST (0.002 USD), /gw/filings/filings?ticker=AQST&form=8-K, /gw/filings/facts?ticker=AQST&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange